Please login to the form below

Not currently logged in
Email:
Password:

Genocea Biosciences

This page shows the latest Genocea Biosciences news and features for those working in and with pharma, biotech and healthcare.

Genital herpes vaccine candidate promising in phase II

Genital herpes vaccine candidate promising in phase II

Genital herpes vaccine candidate promising in phase II. Genocea Biosciences’ GEN-003 found to reduce recurrence and transmission of the virus. ... The vaccine - called GEN-003 and developed by Genocea Biosciences - is a T cell-enabled therapeutic

Latest news

  • Vical's genital herpes vaccine flunks trial Vical's genital herpes vaccine flunks trial

    outbreaks. Last year, Sanofi set up an alliance with Immune Design to develop a therapeutic vaccine for HSV-2 based on their two vaccine candidates, while Genocea Biosciences, Agenus and Tomegavax

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics